Galectin Therapeutics Inc... (GALT)
NASDAQ: GALT
· Real-Time Price · USD
4.67
0.18 (4.01%)
At close: Sep 04, 2025, 3:59 PM
4.77
2.14%
Pre-market: Sep 05, 2025, 09:24 AM EDT
4.01% (1D)
| Bid | 4.37 |
| Market Cap | 299.12M |
| Revenue (ttm) | 36K |
| Net Income (ttm) | -40.34M |
| EPS (ttm) | -0.64 |
| PE Ratio (ttm) | -7.3 |
| Forward PE | -10.2 |
| Analyst | Buy |
| Ask | 4.8 |
| Volume | 230,427 |
| Avg. Volume (20D) | 658,495 |
| Open | 4.48 |
| Previous Close | 4.49 |
| Day's Range | 4.41 - 4.70 |
| 52-Week Range | 0.73 - 4.70 |
| Beta | 0.87 |
About GALT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GALT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GALT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+60.4%
Galectin Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
5 months ago
-19.74%
Galectin Therapeutics shares are trading lower following a FY24 EPS miss.
